Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.

The Lancet. Infectious diseases·2026
Same author

Current challenges in real-world management of Clostridioides difficile infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Two concurrent nationwide healthcare-associated outbreaks of <i>Burkholderia cepacia</i> complex linked to product contamination, UK and Ireland, 2010-2023 - ADDENDUM.

Infection control and hospital epidemiology·2025
Same author

Understanding the impact of different hand drying methods on viral aerosols formation and surface contamination in indoor environments.

Frontiers in public health·2025
Same author

Clostridioides difficile pathogenesis and control.

Nature reviews. Microbiology·2025
Same author

Two concurrent nationwide healthcare-associated outbreaks of <i>Burkholderia cepacia</i> complex linked to product contamination, UK and Ireland, 2010-2023.

Infection control and hospital epidemiology·2025

Related Experiment Video

Updated: Dec 24, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.4K

Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Johanna Sandlund1, Kerrie Davies2, Mark H Wilcox3

  • 1Fluxus, Inc., Santa Clara, California, USA.

Journal of Clinical Microbiology
|April 10, 2020
PubMed
Summary

Current diagnostic tests for Clostridioides difficile infection (CDI) are often inaccurate. Ultrasensitive toxin assays show promise as a standalone diagnostic tool for CDI, potentially improving accuracy.

Keywords:
Clostridioides difficileClostridium difficilediarrheatoxinultrasensitive

More Related Videos

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

20.8K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.0K

Related Experiment Videos

Last Updated: Dec 24, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.4K
Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

20.8K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.0K

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Diagnostic assay development

Background:

  • Current diagnostic tests for Clostridioides difficile infection (CDI) exhibit limitations in specificity and sensitivity.
  • Existing guidelines recommend multistep testing algorithms due to these diagnostic challenges.

Purpose of the Study:

  • To evaluate the potential of ultrasensitive assays for detecting C. difficile toxins as a standalone diagnostic solution for CDI.
  • To assess the improved accuracy offered by ultrasensitive assays compared to current diagnostic methods.

Main Methods:

  • Utilized ultrasensitive assays to measure disease-specific markers (C. difficile toxins) at very low concentrations.
  • Compared the performance and accuracy of these ultrasensitive assays against existing CDI diagnostic approaches (details of large studies lacking in abstract).

Main Results:

  • Ultrasensitive assays can detect C. difficile toxins at significantly lower concentrations.
  • These assays demonstrate potential for improved accuracy in CDI diagnosis compared to current methods.

Conclusions:

  • Ultrasensitive toxin detection assays represent a promising advancement for CDI diagnosis.
  • Further large-scale clinical studies are necessary to validate the performance and accuracy of these assays as a standalone solution.